Bevacizumab injection is given with other medications to treat patients with metastatic (cancer that has spread) carcinoma of the colon or rectum. This medicine is also used to treat a certain type of metastatic lung cancer known as non-squamous, non-small cell lung cancer, and a certain type of brain tumour known as glioblastoma that keeps coming back (recurrent).
Bevacizumab injection is also used in combination with other medicines (for example, interferon alfa) to treat patients with metastatic kidney cancer. It is also used in combination with other medicines (for example, paclitaxel and cisplatin, or paclitaxel and topotecan) to treat patients with cervical cancer that is continuing, keeps coming back, or has spread to other portions of the body.
This medicine is also used in combination with other medicines (for example, paclitaxel, pegylated liposomal doxorubicin, topotecan, carboplatin and paclitaxel, or carboplatin and gemcitabine followed by Avastin alone) to treat patients with platinum-resistant, recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer with or without having preceding surgery.
Bevacizumab injection is also used together with atezolizumab to treat a type of liver cancer known as hepatocellular carcinoma (HCC) that has spread throughout the body (metastatic) or cannot be removed by surgery (unresectable) in patients who have not received other cancer medications by mouth or injection.
Bevacizumab is a substance that helps your body fight cancer. It prevents the growth of specific types of blood vessels into cancer cells. This helps to decrease the growth of cancer cells by starving the cells of nutrients that are required to grow.
The medicine is to be administered only by or under the direct supervision of your doctor.
The product is available in the following dosing forms: